BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 15941870)

  • 21. Iodide kinetics and dosimetry in vivo after transfer of the human sodium iodide symporter gene in rat thyroid carcinoma cells.
    Haberkorn U; Beuter P; Kübler W; Eskerski H; Eisenhut M; Kinscherf R; Zitzmann S; Strauss LG; Dimitrakopoulou-Strauss A; Altmann A
    J Nucl Med; 2004 May; 45(5):827-33. PubMed ID: 15136633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.
    Scholz IV; Cengic N; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1108-16. PubMed ID: 15001595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
    Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
    J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line.
    Smit JW; Shröder-van der Elst JP; Karperien M; Que I; van der Pluijm G; Goslings B; Romijn JA; van der Heide D
    Thyroid; 2000 Nov; 10(11):939-43. PubMed ID: 11128720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
    Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase reverse transcriptase promoter-driven expression of iodine pump genes for targeted radioiodine therapy of malignant glioma cells.
    Tan J; Li W; Wang P
    Chin J Cancer; 2011 Aug; 30(8):574-80. PubMed ID: 21801606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3).
    Sieger S; Jiang S; Schönsiegel F; Eskerski H; Kübler W; Altmann A; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):748-56. PubMed ID: 12541134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
    Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
    J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium-iodine symporter gene expression controlled by the EGR-1 promoter: biodistribution, imaging and in vitro radionuclide therapy with Na(131)I.
    Tang J; Wang X; Xu Y; Shi Y; Liu Z; Yang Y
    Technol Cancer Res Treat; 2015 Feb; 14(1):61-9. PubMed ID: 24354753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.
    Elisei R; Vivaldi A; Ciampi R; Faviana P; Basolo F; Santini F; Traino C; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2389-95. PubMed ID: 16537683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM; Hagan CR; Mitrofanova EE; Panchal RG; Guo J; Link CJ
    Cancer Gene Ther; 2003 Jan; 10(1):14-22. PubMed ID: 12489024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of iodide uptake and efflux in various human thyroid cancer cells by expressing sodium iodide symporter gene via a recombinant adenovirus.
    Lee WW; Lee B; Kim SJ; Jin J; Moon DH; Lee H
    Oncol Rep; 2003; 10(4):845-9. PubMed ID: 12792733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.
    Kim YH; Youn H; Na J; Hong KJ; Kang KW; Lee DS; Chung JK
    Theranostics; 2015; 5(1):86-96. PubMed ID: 25553100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene therapy with sodium/iodide symporter in hepatocarcinoma.
    Haberkorn U
    Exp Clin Endocrinol Diabetes; 2001; 109(1):60-2. PubMed ID: 11573143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific activation of sodium iodide symporter gene in hepatoma using alpha-fetoprotein promoter combined with hepatitis B virus enhancer (EIIAPA).
    Liu RS; Hsieh YJ; Ke CC; Chen FD; Hwu L; Wang FH; Hwang JJ; Chi CW; Lee CH; Yeh SH
    Anticancer Res; 2009 Jan; 29(1):211-21. PubMed ID: 19331152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells.
    Li W; Ain KB
    Endocr Relat Cancer; 2010 Jun; 17(2):383-98. PubMed ID: 20228127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
    Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
    Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.
    Shimura H; Haraguchi K; Miyazaki A; Endo T; Onaya T
    Endocrinology; 1997 Oct; 138(10):4493-6. PubMed ID: 9322970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium butyrate enhances the expression of baculovirus-mediated sodium/iodide symporter gene in A549 lung adenocarcinoma cells.
    Guo R; Zhang Y; Liang S; Xu H; Zhang M; Li B
    Nucl Med Commun; 2010 Oct; 31(10):916-21. PubMed ID: 20683361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.